skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi, in follow up to my previous question, what are your thoughts on these three possible additions to my TFSA. Again, in your view which two have the biggest up side potential for the next year or two? Thanks
Read Answer Asked by Henry on July 19, 2016
Q: CXR has lots of headwinds (brexit, pricing environment, debt levels, questions about their business model, etc). if debt level is one of the biggest headwinds the company faces, and current cash flow will take years to pay down debt, is it possible the company issues shares, even at this really reduced price, to pay down debt?
Read Answer Asked by Richard on July 18, 2016
Q: I am puzzled by this company. Other than their SG&A being too high the company seems, on the surface, to be improving. They had a major fire at their plant in PQ which created a supply issue with regards their customer base but that has been resolved. They had some problems with a few other countries trying to ignore their IP but that has pretty much resolved. There are only two countries that can sell their product (krill oil) into China and Canada is one of them. They just announced their first quarter results as below;
Revenues reached $11.3 million, up 270% versus last year
• Gross margin on sales rose to 30.5%
• Nutraceutical segment generated positive Adjusted EBITDA of $1.1 million compared to a loss of $3.2 million a year ago
• Completed first sale in Chinese market and of MaxSimil® in July
• Cash balance of $5 million
• Revised Revenues guidance from $41 to $43 million
I have my opinion on this company but I would appreciate your perspective.

Thanks
Pat Sherman
Read Answer Asked by Patrick on July 13, 2016
Q: I recently sold a small position in CZO after the run up and their announcement today. I did not like the private placement doubling while simultaneously lower the strike price on warrants to $1.50... I thought the previously sized raise and terms were very strategic but now I think there could easily be some cash over hang and general selling pressure with the raise and warrants priced much lower. Do you share this view? What do you think is a decent re-entry point for a higher risk investor?
Thanks
Read Answer Asked by Scott on July 12, 2016
Q: Wondering your opinion on recent news about MPH -- FDA seems to want more information on their drug application. From what I can gather this seems to be a bump in the road from which MPH can recover. Do you think this development is enough to change fundamentals? Would this trigger a sell for you on a longer term hold?
Read Answer Asked by JONAS on July 11, 2016
Q: Hello,
I have kept averaging down on this and currently have big losses. Yesterday, a BNN guest said that this is a non investable company.

Should I just sell and bank the loses? It's a registered account so can't even claim losses, keep average down? Hold my nose for a year or so? Can it go belly up?

Thanks
Marios
Read Answer Asked by Marios on July 06, 2016